These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 10202883)

  • 41. Serum progesterone level effects on the outcome of in vitro fertilization in patients with different ovarian response: an analysis of more than 10,000 cycles.
    Xu B; Li Z; Zhang H; Jin L; Li Y; Ai J; Zhu G
    Fertil Steril; 2012 Jun; 97(6):1321-7.e1-4. PubMed ID: 22494924
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Luteal phase and clinical outcome after human menopausal gonadotrophin/gonadotrophin releasing hormone antagonist treatment for ovarian stimulation in in-vitro fertilization/intracytoplasmic sperm injection cycles.
    Albano C; Smitz J; Tournaye H; Riethmüller-Winzen H; Van Steirteghem A; Devroey P
    Hum Reprod; 1999 Jun; 14(6):1426-30. PubMed ID: 10357952
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of HCG-day serum progesterone and oestradiol concentrations on pregnancy outcomes in GnRH agonist cycles.
    Wu Z; Li R; Ma Y; Deng B; Zhang X; Meng Y; Chen X; Liu P; Qiao J
    Reprod Biomed Online; 2012 May; 24(5):511-20. PubMed ID: 22417667
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effects of low-dose human chorionic gonadotropin combined with human menopausal gonadotropin protocol on women with hypogonadotropic hypogonadism undergoing ovarian stimulation for in vitro fertilization.
    Jiang S; Kuang Y
    Clin Endocrinol (Oxf); 2018 Jan; 88(1):77-87. PubMed ID: 28960429
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparative study of hormonal dynamics in pregnant and nonpregnant cycles during pulsatile subcutaneous administration of human menopausal gonadotropin in anovulatory infertile women.
    Nakamura Y; Yoshimura Y; Oda T; Shiokawa S; Yoshinaga A; Akiba M
    Fertil Steril; 1993 Aug; 60(2):254-61. PubMed ID: 8339820
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Elevated serum progesterone-to-estradiol ratio during gonadotropin stimulation for intrauterine insemination or in vitro fertilization is not associated with diminished ovarian reserve.
    Hofmann GE; Khoury J; Michener C
    Fertil Steril; 2002 Jul; 78(1):47-50. PubMed ID: 12095489
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Role of luteal phase support on gonadotropin ovulation induction cycles in patients with polycystic ovary syndrome.
    Yazici G; Savas A; Tasdelen B; Dilek S
    J Reprod Med; 2014; 59(1-2):25-30. PubMed ID: 24597283
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Flexibility in starting ovarian stimulation at different phases of the menstrual cycle for treatment of infertile women with the use of in vitro fertilization or intracytoplasmic sperm injection.
    Qin N; Chen Q; Hong Q; Cai R; Gao H; Wang Y; Sun L; Zhang S; Guo H; Fu Y; Ai A; Tian H; Lyu Q; Daya S; Kuang Y
    Fertil Steril; 2016 Aug; 106(2):334-341.e1. PubMed ID: 27114329
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Luteal phase support in ovarian induction cycles using human chorionic gonadotropin or oral progestagens.
    Zayed FF; El-Jallad MF; Al-Chalabi HA
    Saudi Med J; 2003 Jan; 24(1):34-6. PubMed ID: 12590270
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Should progesterone on the human chorionic gonadotropin day still be measured?
    Martinez F; Rodriguez I; Devesa M; Buxaderas R; Gómez MJ; Coroleu B
    Fertil Steril; 2016 Jan; 105(1):86-92. PubMed ID: 26453983
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Subtle progesterone rise in the single-dose gonadotropin-releasing hormone antagonist (cetrorelix) stimulation protocol in patients undergoing in vitro fertilization or intracytoplasmic sperm injection cycles.
    Seow KM; Lin YH; Huang LW; Hsieh BC; Huang SC; Chen CY; Chen PH; Tzeng CR; Hwang JL
    Gynecol Endocrinol; 2007 Jun; 23(6):338-42. PubMed ID: 17616858
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Human chorionic gonadotrophin is a better luteal support than progesterone in ultrashort gonadotrophin-releasing hormone agonist/menotrophin in-vitro fertilization cycles.
    Golan A; Herman A; Soffer Y; Bukovsky I; Caspi E; Ron-El R
    Hum Reprod; 1993 Sep; 8(9):1372-5. PubMed ID: 8253920
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Human chorionic gonadotropin as a predictor of outcome in assisted reproductive technology pregnancies.
    Homan G; Brown S; Moran J; Homan S; Kerin J
    Fertil Steril; 2000 Feb; 73(2):270-4. PubMed ID: 10685527
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Progesterone alone versus progesterone combined with HCG as luteal support in GnRHa/HMG induced IVF cycles: a randomized clinical trial.
    Mochtar MH; Hogerzeil HV; Mol BW
    Hum Reprod; 1996 Aug; 11(8):1602-5. PubMed ID: 8921100
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The value of a single serum progesterone measurement in the midluteal phase as a criterion of a potentially fertile cycle ("ovulation") derived form treated and untreated conception cycles.
    Hull MG; Savage PE; Bromham DR; Ismail AA; Morris AF
    Fertil Steril; 1982 Mar; 37(3):355-60. PubMed ID: 7060786
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The pregnancy rates with intrauterine insemination (IUI) in superovulated cycles employing different protocols (clomiphen citrate (CC), human menopausal gonadotropin (HMG) and HMG+CC) and in natural ovulatory cycle.
    Mahani IM; Afnan M
    J Pak Med Assoc; 2004 Oct; 54(10):503-5. PubMed ID: 15552282
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Progesterone elevation on the day of human chorionic gonadotropin administration is not the only factor determining outcomes of in vitro fertilization.
    Tsai YR; Huang FJ; Lin PY; Kung FT; Lin YJ; Lin YC; Lan KC
    Fertil Steril; 2015 Jan; 103(1):106-11. PubMed ID: 25455869
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A prospective randomized study on oestradiol valerate supplementation in addition to intravaginal micronized progesterone in buserelin and HMG induced superovulation.
    Smitz J; Bourgain C; Van Waesberghe L; Camus M; Devroey P; Van Steirteghem AC
    Hum Reprod; 1993 Jan; 8(1):40-5. PubMed ID: 8458924
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Estradiol/progesterone substitution in the luteal phase improves pregnancy rates in stimulated cycles--but only in younger women.
    Gleicher N; Brown T; Dudkiewicz A; Karande V; Rao R; Balin M; Campbell D; Pratt D
    Early Pregnancy (Cherry Hill); 2000 Jan; 4(1):64-73. PubMed ID: 11719823
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Delaying human chorionic gonadotropin administration in human menopausal gonadotropin-induced cycles decreases successful in vitro fertilization of human oocytes.
    Laufer N; DeCherney AH; Tarlatzis BC; Zuckerman AL; Polan ML; Dlugi AM; Graebe R; Barnea ER; Naftolin F
    Fertil Steril; 1984 Aug; 42(2):198-203. PubMed ID: 6430722
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.